Literature DB >> 11806564

Laparoscopic pyeloplasty, initial experience in the management of UPJO.

V J Gnanapragasam1, T G Armitage.   

Abstract

AIM: Laparoscopic pyeloplasty (LP) has emerged in the last 8 years as an alternative to open surgery. We here present the results of our series of patients and evaluate LP in the management of ureteropelvic junction obstruction (UPJO). PATIENTS AND METHODS: Patients with UPJO confirmed by renogram and/or symptoms were offered surgical correction by LP. The risks, alternatives, and novelty of the technique at our centre were explained to obtain informed consent. Patients were assessed pre- and postoperatively and data including operative time, analgesic requirements, time to self care and full activity were recorded. Fifteen patients with a mean age of 38.4 years were recruited in whom 13 successful Anderson Hayes transperitoneal LPs were performed in 12 patients.
RESULTS: Mean operative time was 261 min and blood loss was minimal. Analgesic requirements were also minimal with patients requiring PCA for an average of 1.1 days. Average days to free fluids were 1.5 days and the mean hospital stay was 4.4 days. Average number of days to self care and full activity were 3.2 and 12.2 days, respectively. Patients in employment returned to work after an average of 4.4 weeks, In 9/10 cases with pre-operative loin pain, patients had symptom relief following surgery. Postoperative renogram at 6 months confirmed improved drainage in 12 LP procedures. At a mean follow up of 20 months, 11/12 patients remain symptomatically well.
CONCLUSIONS: In this series, LP operative times and outcome closely match those of larger series and the functional results are comparable to open pyeloplasty. We conclude that LP is a suitable first line option for UPJO surgery provided standard laparoscopic equipment and a trained urologist are available.

Entities:  

Mesh:

Year:  2001        PMID: 11806564      PMCID: PMC2503413     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  24 in total

1.  Assessment of alternative tissue approximation techniques for laparoscopy.

Authors:  C G Eden; M J Coptcoat
Journal:  Br J Urol       Date:  1996-08

Review 2.  Treatment options for pelvi-ureteric junction obstruction: implications for practice and training.

Authors:  C G Eden
Journal:  Br J Urol       Date:  1997-09

3.  Laparoscopic dismembered pyeloplasty: preliminary report.

Authors:  F Recker; B Subotic; M Goepel; R Tscholl
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

4.  Laparoscopic dismembered pyeloplasty in children: preliminary results.

Authors:  H L Tan; J P Roberts
Journal:  Br J Urol       Date:  1996-06

5.  Acucise endopyelotomy: assessment of long-term durability.

Authors:  R B Nadler; G S Rao; M S Pearle; S Y Nakada; R V Clayman
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

6.  Laparoscopic pyeloplasty: experience with the initial 30 cases.

Authors:  R G Moore; T D Averch; P G Schulam; J B Adams; R N Chen; L R Kavoussi
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

7.  Comparison of open and endourologic approaches to the obstructed ureteropelvic junction.

Authors:  J D Brooks; L R Kavoussi; G M Preminger; W W Schuessler; R G Moore
Journal:  Urology       Date:  1995-12       Impact factor: 2.649

8.  Long-term follow-up of Acucise incision of ureteropelvic junction obstruction and ureteral strictures.

Authors:  T D Cohen; M B Gross; G M Preminger
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

9.  Laparoscopic and retroperitoneoscopic repair of ureteropelvic junction obstruction.

Authors:  G Janetschek; R Peschel; S Altarac; G Bartsch
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

10.  Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction: preliminary experience.

Authors:  S Y Nakada; E M McDougall; R V Clayman
Journal:  Urology       Date:  1995-08       Impact factor: 2.649

View more
  3 in total

1.  The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

Authors:  Jean C-Y Tien; Zhaoliang Liu; Lan Liao; Fen Wang; Yixiang Xu; Ye-Lin Wu; Niya Zhou; Michael Ittmann; Jianming Xu
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

Review 2.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

3.  Our experience with open dismembered pyeloplasty for uretero-pelvic junction obstruction.

Authors:  Ali Shahzad; Iqbal Shahzad; Muhammad Umar Baloch
Journal:  Pak J Med Sci       Date:  2014-01       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.